The localization of cathepsin D with a Biotin-labelled pepstatin  by Matthews, Ian T.W. et al.
Volume 134, number 2 FEBS LETTERS November 1981 
THE LOCALIZATION OF CATHEPSIN D WITH A BIOTIN-LABELLED PEPSTATIN 
Ian T. W. MATTHEWS, Robert S. DECKER* and C. Graham KNIGHT 
Tissue Physiology Department, Strangeways Laboratory, Worts’ Causeway, Cambridge CBl 4RN, England 
Received 29 September 1981 
1. Introduction 
Proteolytic enzymes are believed to be actively 
involved in the destruction of articular cartilage which 
accompanies chronic joint inflammation [ 11. The 
aspartate proteinase, cathepsin D, is secreted by cul- 
tured cartilage stimulated to resorb [2] and there has 
been considerable interest in the possible role of this 
enzyme in the degradation of proteoglycans in arthritis 
[3]. Immunohistochemical methods have demonstrated 
extracellular cathepsin D at the pannus-articular 
cartilage junction in rheumatoid arthritic tissue [4]. 
However, such a procedure does not distinguish 
between the active and inactive forms of the enzyme. 
Modified forms of the tight-binding, active-site- 
directed inhibitor pepstatin [isovaleryl-L-valyl-L- 
valyl-(3S,4S)lt-amino-3-hydroxy-6-methylhep- 
tanoyl-L-alanyl-(3S,4S)-4-amino-3-hydroxy-6- 
methylheptanoic acid] could prove useful in localiz- 
ing cathepsin D [5,6]. Since this class of inhibitor 
requires the native, active enzyme structure for effi- 
cient interaction [7], the binding of this inhibitor can 
locate potentially active enzyme intra- or extracellu- 
larly [6]. This report illustrates that a biotinyl-pep- 
statin, in conjunction with tetramethylrhodamine- 
labelled avidin, is a useful probe to demonstrate 
cathepsin D within human synovial fibroblasts. 
given by Dr G. Evin, INSERM Unite 36, Paris. Bio- 
tinyl-N-hydroxysuccinimide was prepared as in [9]. 
1,2-Diaminoethane was from Aldrich. Avidin, colla- 
genase type V and bovine trypsin type I were from 
Sigma. Cathepsin D from human liver was kindly 
given by Dr A. J. Barrett of this laboratory. Tetra- 
methylrhodamine isothiocyanate was from Poly- 
sciences. Sephadex LH-20 and G-25 were from Phar- 
macia. AG-SOW-X2 resin (H’ form; 200400 mesh) 
was from BioRad Labs. Plastic Petri dishes and flasks 
were from Sterilin. Dulbecco’s modified Eagle’s 
medium and foetal calf serum were from GIBCO. 
Human synovial cells were prepared from sterile 
biopsy tissue obtained from the Department of 
Orthopaedic Surgery, New Addenbrooke’s Hospital, 
Cambridge. 
2.1 .Preparation of biotin-labelled pepstatins 
2. Materials and methods 
Pepstatin was from the Protein Research Founda- 
tion. Benzotriazol-l-yloxytris(dimethylamino)phos- 
phonium hexafluorophosphate (BOP) [8] was kindly 
N-Pepstatinyl-cystamine was synthesised as in [6]. 
N-Pepstatinyl-1,2-diaminoethane was prepared in a 
similar manner. Briefly, pepstatin (10 mg, 14.6 pmol) 
and 1,2-diaminoethane (10 ~1, 149 pmol) were dis- 
solved in dimethylsulfoxide/dimethylformamide (5 : 1, 
v/v; 1.2 ml). Triethylamine (64 ~1,460 pmol) and 
BOP (13 mg, 25 pmol) were added. After 24 h at 
21°C the product was purified on Sephadex LH-20 
and on Dowex AG-5OW-X2 as in [lo]. The product 
(yield: 7 mg, 66%) was homogeneous by TLC on silica 
gel in butan-1-al/n-butyl acetate/acetic acid/water 
(4:4: 1 :l , by vol.). 
* Present address: Department of Cell Biology, University of 
Texas Health Science Center at Dallas, Dallas, TX 75235, 
USA 
To each pepstatinyl-amine (3.62 pmol) in dimethyl- 
formamide (1 ml) at -5°C was added [ 14C] biotin-N- 
hydroxysuccinimide (36.2 pmol, 24.4 yCi/mmol). 
After 48 h at 2 1°C the biotinyl-pepstatins were puri- 
fied on Sephadex LH-20 in ethanol. Both compounds 
were ninhydrin negative and showed only one radio- 
labelled component inhibitory towards cathepsin D. 
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2.2. Inhibition titrations 
Cathepsin D activity was measured under standard 
assay conditions [ 1 I]. The assays were started by the 
addition of buffered haemoglobin to the mixture of 
cathepsin D (1 .13 units, 0.064 nmol) andN-pepstatinyl- 
N’-biotinyl-cystamine or N-pepstatinyl-N’-biotinyl- 
1,2-diaminoethane, with avidin (10 ~1, 1 mg/ml in 
0.1 M NaCl) present or absent. The trichloroacetic 
acid-soluble products of digestion of haemoglobin 
were measured by their A 2s0. Apparent dissociation 
constants (Kd) were calculated from the shapes of 
the titration curves [ lo,1 21. 
2.3. Preparation of formyl tetramethylrhodamine- 
labelled avidin 
To avidin (10 mg, 0.15 pmol) in 0.15 M phosphate 
buffer (pH 7.4) (1 ml) was added tetramethylrhod- 
amine isothiocyanate (0.144 mg, 0.34 pmol) in dry 
acetone (0.1 ml). The pH of this solution was altered 
to pH 9.5 with 0.1 M NaOH and it was stirred at 4°C 
overnight. The product was purified on Sephadex 
G-25 in 0.02 M phosphate-buffered saline (pH 7.4) 
and formylated as in [ 131. 
2.4. Cell culture 
Minced synovium (0.5 g) was placed in Dulbecco’s 
modified Eagle’s medium containing collagenase type 
V (1 mg/ml) at 37°C in an atmosphere of COJair 
(1: 19). After 18 h, clumps of cells were collected by 
centrifugation, washed twice in fresh medium and 
resuspended in medium containing bovine trypsin 
type I(0.25 mg/ml) and 1 mM disodium EDTA. After 
30 min at 37°C the trypsin was inactivated by adding 
an equal volume of 20% (v/v) heat-inactivated foetal 
calf serum. The cell suspension was then plated onto 
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Fig.1. Structures of: (a) N-pepstatinyl-A”-biotinyl-cystamine; 
(b) N-pepstatinyl-A”-biotinyl-1,2diaminoethane. 
acid-etched coverslips (2.2 cm’) at 1 X 10’ cells/cm’ 
and cultured at 37°C in COJair (1: 19) in medium 
containing 10% (v/v) foetal calf serum. Confluent 
coverslip cultures of human synovial cells were rinsed 
3 times in serum-free Dulbecco’s modified Eagle’s 
medium. The coverslips were treated with 4% (w/v) 
paraformaldehyde for 3 min at 20°C at pH 5 .O in 
0.05 M acetate buffer, or at pH 7.4 in 0.05 M phos- 
phate buffer, and then washed in several changes of 
buffer at the same pH-value for 30 min. Both buffers 
contained 0.1 M NaCl and 0.1% Brij 35. 
2.5. Cellular staining 
The coverslips were immersed in either 1 PM 
N-pepstatinyl-N’-biotinyl-1,2-diaminoethane orll/;pep- 
statinyl-N’-biotinyl-cystamine at pH 5 .O or pH 7.4 for 
30 min at 2 1 “C. The cells were then rapidly rinsed 
and incubated with formyl tetramethylrhodamine- 
labelled avidin (10 &ml) at pH 5 .O or pH 7.4 for 1 h. 
After a rapid rinse in the corresponding buffer the 
coverslips were mounted in glycerol. The cells were 
examined in a Zeiss fluorescence microscope equipped 
with rhodamine optics. All observations were recorded 
on Kodak Tri-X or Ektachrome 400 film uprated to 
ASA 1600. 
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Fig.2. Inhibition of cathepsin D by (a) N-pepstatinyl-N’-bio- 
tinyl-cystamine and (b)N-pepstatinyl-A”-biotinyl-1,2-diamino- 
ethane in the presence (a) and absence (9) of avidin. 
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3. Results 
Two biotinyl-pepstatin derivatives have been 
prepared and examined for their inhibitory properties 
towards cathepsin D and staining characteristics with 
human synovial cells. When N-pepstatinyl-N’-biotinyl- 
cystamine and A’-pepstatinyl-N’-biotinyl-1,2-diamino- 
ethane (fig.1) were titrated against cathepsin D, both 
derivatives behaved like pepstatin [lo] and bound 
tightly and stoicheiometrically to the enzyme. When 
similar titrations were made in the presence of avidin 
N-pepstatinyl-N’-biotinyl-cystamine displayed the 
same inhibitory properties (fig.2a), giving apparent 
dissociation constant values of 0.13 nM and 0.07 nM, 
in the presence and absence of avidin, respectively. 
However, the short chain derivative, N-pepstatinyl-N’- 
biotinyl-1,2-diaminoethane showed a marked dissoci- 
ation in the presence of avidin (fig.2b) and had appar- 
ent dissociation constants of 2.3 nM in the presence 
of avidin and 0.36 nM in the absence of avidin. This 
compound failed to stain human synovial cell lyso- 
somes (fig.3a) ~ By contrast, when fixed synovial 
fibroblasts were incubated with IV-pepstatinyl-N’-bio- 
tinyl-cystamine at pH 5 .O, and stained with formyl 
tetramethylrhodamine-labelled avidin, considerable 
lysosomal staining could be seen in the fluorescence 
microscope (fig3b). At pH 7.4, however, when pep- 
statin derivatives fail to bind to cathepsin D [IO], no 
intracellular fluorescent staining could be discerned 
(fig.3c). 
Fig.3. Distribution of lysosomal cathepsin D in human synovial cells determined with N-pepstatinyl-N’-biotinyl-1,2diaminoethane 
at pH 5.0 (a), and with N-pepstatinyl-N’-biotinyl-cystamine at pH 5.0 (b) and pH 7.4 (c). Lysosomal granules are seen only in (b). 
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4. Discussion References 
These observations indicate that N-pepstatinyl-iV’- 
biotinylcystamine is a useful probe to assess the distri- 
bution of lysosomal cathepsin D in human synovial 
cells. The intracellular pattern of cathepsin D staining 
revealed by this reagent closely resembles that seen 
by immunohistochemical methods [6]. Unlike the 
immunological approach, which requires extensive 
species-specific enzyme purification and antibody 
production before localization studies can commence, 
labelled pepstatin probes are specific for aspartate 
proteinases regardless of origin [ 141. Additionally, 
such reagents make it possible to locate potentially 
active enzyme within the cell. Lastly, the develop- 
ment of biotinyl-pepstatin extends our capability to 
localize cathepsin D to the ultrastructural level. Con- 
jugation of avidin with colloidal gold [ 151, for 
example, will provide an electron-dense probe suitable 
for high resolution localization. 
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